Showing results (311-320 of 458) with videos related to
Sort By:
Pageof 46
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infectionTroy J Kemp, Allan Hildesheim, Alfonso García-Piñeres, et al.The Journal of Infectious Diseases|March 16, 2011
Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical diseaseAnil K Chaturvedi, Hormuzd A Katki, Allan Hildesheim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2018
Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive WomenMegan A Clarke, Ana Gradissimo, Mark Schiffman, et al.International Journal of Cancer|June 2, 2011
The age-specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: implications for screen-and-treat strategiesJulia C Gage, Kayode O Ajenifuja, Nicolas A Wentzensen, et al.Journal of Clinical Microbiology|August 19, 2007
Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesionsPatti E Gravitt, Leen Jan van Doorn, Wim Quint, et al.International Journal of Cancer|November 26, 2008
Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in OklahomaNicolas Wentzensen, Mark Schiffman, S Terence Dunn, et al.International Journal of Cancer|May 14, 2017
Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancerMegan A Clarke, Patricia Luhn, Julia C Gage, et al.JAMA|August 21, 2007
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trialAllan Hildesheim, Rolando Herrero, Sholom Wacholder, et al.Journal of the National Cancer Institute|November 18, 2017
Relative Performance of HPV and Cytology Components of Cotesting in Cervical ScreeningMark Schiffman, Walter K Kinney, Li C Cheung, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2009
Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisitedJill Koshiol, Allan Hildesheim, Paula Gonzalez, et al.Pageof 46